Analytical Data
-
Gene name
TCEANC2
- Application
-
Alternative Names
TCEANC2; C1orf83; Transcription elongation factor A N-terminal and central domain-containing protein 2
-
Species
Human
-
Source
E. coli
-
Tag
N- His-SUMO
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q96MN5
-
Expression Region
1-208aa
-
Molecular Weight
40.1 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
TCEANC2, a member of the TCE (T-cell-specific enhancer) family, is a newly identified protein that plays a significant role in the regulation of immune responses. Its study arises from the growing interest in understanding how specific proteins contribute to the functioning of T-cells, which are crucial for adaptive immunity. Research into TCEANC2 is motivated by the need to explore its function in T-cell activation, proliferation, and differentiation, particularly in the context of diseases such as cancer and autoimmune disorders. Previous studies have indicated that TCE family proteins are involved in the transcriptional regulation of various genes associated with immune responses. However, the exact mechanisms by which TCEANC2 influences T-cell behavior remain largely unexplored. Investigating TCEANC2's structure, expression patterns, and interaction with other intracellular pathways may provide insights into its potential as a therapeutic target. Additionally, understanding TCEANC2's role could open up new avenues for developing strategies that enhance immune responses, improve cancer immunotherapy, or mitigate autoimmune diseases. As such, the research on TCEANC2 is positioned at the intersection of immunology and molecular biology, holding promise for advancing our knowledge of immune regulation and its implications for human health.
